158 related articles for article (PubMed ID: 20648067)
1. Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.
Fallano KA; Ibrahim M; Nguyen QD; Do DV
Can J Ophthalmol; 2010 Dec; 45(6):649-50. PubMed ID: 20648067
[No Abstract] [Full Text] [Related]
2. Optical coherence tomographic angiography in type 1 idiopathic macular telangiectasia.
Pappuru RR; Peguda HK; Dave VP
Clin Exp Optom; 2018 Jan; 101(1):143-144. PubMed ID: 28295586
[No Abstract] [Full Text] [Related]
3. In vivo evaluation of photoreceptor mosaic in type 2 idiopathic macular telangiectasia using adaptive optics.
Massamba N; Querques G; Lamory B; Querques L; Souied E; Soubrane G
Acta Ophthalmol; 2011 Nov; 89(7):e601-3. PubMed ID: 20809908
[No Abstract] [Full Text] [Related]
4. Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy.
Gillies MC; Mehta H; Bird AC
JAMA Ophthalmol; 2015 Aug; 133(8):951-4. PubMed ID: 26067680
[TBL] [Abstract][Full Text] [Related]
5. ASSOCIATION BETWEEN CHANGES IN MACULAR VASCULATURE IN OPTICAL COHERENCE TOMOGRAPHY- AND FLUORESCEIN- ANGIOGRAPHY AND DISTRIBUTION OF MACULAR PIGMENT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Zeimer M; Gutfleisch M; Heimes B; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2015 Nov; 35(11):2307-16. PubMed ID: 26465618
[TBL] [Abstract][Full Text] [Related]
6. OUTER RETINA CAPILLARY INVASION AND ELLIPSOID ZONE LOSS IN MACULAR TELANGIECTASIA TYPE 2 IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Gaudric A; Krivosic V; Tadayoni R
Retina; 2015 Nov; 35(11):2300-6. PubMed ID: 26441270
[TBL] [Abstract][Full Text] [Related]
7. Occlusive idiopathic juxtafoveolar retinal telangiectasis type 4.
Matonti F; Chazalon E; Hoffart L; Roux L; Denis D
Can J Ophthalmol; 2013 Jun; 48(3):e45-7. PubMed ID: 23769792
[No Abstract] [Full Text] [Related]
8. [Idiopathic juxtafoveolar teleangiectasia 2a in spectral domain optical coherence tomography (SdOCT)].
Laudencka A; Kałuzny JJ; Sikorski B; Kałuzny BJ; Kucharczuk J; Burduk M
Klin Oczna; 2012; 114(1):11-7. PubMed ID: 22783737
[TBL] [Abstract][Full Text] [Related]
9. Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2.
Nunes RP; Goldhardt R; de Amorim Garcia Filho CA; Thorell MR; Abbey AM; Kuriyan AE; Modi YS; Shah M; Yehoshua Z; Gregori G; Feuer W; Rosenfeld PJ
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):162-70. PubMed ID: 25707040
[TBL] [Abstract][Full Text] [Related]
10. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography.
Park SJ; Woo SJ; Park KH; Hwang JM; Chung H
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3673-9. PubMed ID: 20164460
[TBL] [Abstract][Full Text] [Related]
11. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Therapeutic Challenges.
Corvi F; Lattanzio R; Miserocchi E; Querques L; Bandello F; Querques G; Croft DE; Wykoff CC
Retina; 2016 Nov; 36(11):2239-2245. PubMed ID: 27322945
[No Abstract] [Full Text] [Related]
13. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
[TBL] [Abstract][Full Text] [Related]
15. Re: Spaide et al.: Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2 (Ophthalmology 2015;122:2261-9).
Chen Z; Huang D; Izatt JA; Wang RK; Werner JS; Yasuno Y
Ophthalmology; 2016 Mar; 123(3):e24. PubMed ID: 26902576
[No Abstract] [Full Text] [Related]
16. Long-term changes in autosomal dominant vitreoretinochoroidopathy (ADVIRC).
Wöster L; Roider J
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):441-442. PubMed ID: 28975401
[No Abstract] [Full Text] [Related]
17. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
Spaide RF; Klancnik JM; Cooney MJ
JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
[TBL] [Abstract][Full Text] [Related]
18. The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2.
Zhu M; Krilis M; Gillies MC
Retina; 2013 Sep; 33(8):1547-50. PubMed ID: 23974952
[TBL] [Abstract][Full Text] [Related]
19. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
[TBL] [Abstract][Full Text] [Related]
20. Unusual presentations of type 2 idiopathic macular telangiectasia.
Atmani K; Querques G; Zourdani A; Benhamou N; Souied EH
Ophthalmologica; 2013; 230(3):126-30. PubMed ID: 23969580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
